NASDAQ:FWP Forward Pharma A/S - FWP Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forward Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Share Today's Range$1.95▼$1.9550-Day Range$1.79▼$3.1952-Week Range$1.50▼$6.48VolumeN/AAverage Volume7,484 shsMarket Capitalization$13.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Forward Pharma A/S (NASDAQ:FWP) StockForward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.Read More Receive FWP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address FWP Stock News HeadlinesMarch 30, 2023 | seekingalpha.comFWPAY Forward Pharma A/SMarch 24, 2023 | msn.comBayer's pharma chief hopes EU takes time to improve drug rules reformMarch 31, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastMarch 12, 2023 | thestreet.comWhy Acadia Pharma's First Drug Approval Isn't Moving Stock HigherMarch 6, 2023 | benzinga.comMindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales PartnershipFebruary 24, 2023 | msn.comThis Purdue Pharma scion is selling $30M in property amid opioid crisisFebruary 20, 2023 | msn.comPiramal Pharma is emerging as a new pharma giant; what's driving the company's growth?December 29, 2022 | msn.comChina Reopening Prospects Lend Some Support to European Equities But Uncertain Outlook WeighsMarch 31, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastDecember 22, 2022 | finanznachrichten.deForward Pharma A/S: Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketDecember 19, 2022 | finance.yahoo.comForward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketDecember 9, 2022 | msn.comEuropean Equities Rise Modestly Friday, But End Week LowerNovember 12, 2022 | msn.comEuropean ADRs Surge Higher as Global Markets React to US Inflation DataOctober 13, 2022 | msn.comEuropean ADRs Move Higher in Thursday TradingSeptember 30, 2022 | forbes.comHow Social Media Analytics Is Transforming Pharma Decision MakingAugust 10, 2022 | usatoday.comUS forward Matthew Hoppe joins 2nd-tier MiddlesbroughAugust 8, 2022 | finance.yahoo.comFortune and Great Place to Work® Name Forward Networks One of the 2022 Best Small Workplaces™, Ranking #20 NationallyJuly 2, 2022 | thestreet.comForward Pharma A/S NewsApril 11, 2022 | investing.comForward Pharma Reports FY 21 EPS of $0.02April 8, 2022 | finance.yahoo.comForward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021December 16, 2021 | benzinga.comForward Pharma Shares Resume Trading, Pull Back From HighsDecember 16, 2021 | benzinga.comForward Pharma Has Been Granted Australian Patent Titled 'Combination therapy for treatment of multiple sclerosis'September 7, 2021 | finance.yahoo.comWhy is Forward Pharma Stock Plunging During Premarket Tuesday?September 6, 2021 | finance.yahoo.comForward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal HearingJune 28, 2021 | finance.yahoo.comWe're Hopeful That Forward Pharma (NASDAQ:FWP) Will Use Its Cash WiselyJune 14, 2021 | finance.yahoo.comIs Forward Pharma A/S (FWP) Going to Burn These Hedge Funds?June 11, 2021 | marketwatch.comForward Pharma ADRs Up 26%See More Headlines Receive FWP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address FWP Company Calendar Last Earnings9/01/2016Today3/31/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FWP CUSIPN/A CIK1604924 Webwww.forward-pharma.com Phone(453) 344-4242FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio18.43 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.09 per share Price / Book0.19Miscellaneous Outstanding Shares7,091,000Free Float2,023,000Market Cap$13.83 million OptionableNot Optionable Beta1.38 Key ExecutivesMr. Florian Schonharting M.Sc. (Econ) (Age 53)Co-Founder & Chairman Dr. Claus Bo Søndergaard Svendsen M.D. (Age 45)Ph.D., Chief Exec. Officer Mr. Thomas Carbone (Age 65)VP of Fin. & Controller Key CompetitorsRegulus TherapeuticsNASDAQ:RGLSGelesisNYSE:GLSApplied Molecular TransportNASDAQ:AMTICellectar BiosciencesNASDAQ:CLRBNanoViricidesNYSE:NNVCView All Competitors FWP Stock - Frequently Asked Questions How were Forward Pharma A/S's earnings last quarter? Forward Pharma A/S (NASDAQ:FWP) issued its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. What other stocks do shareholders of Forward Pharma A/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Celldex Therapeutics (CLDX), Catalyst Pharmaceuticals (CPRX), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Onconova Therapeutics (ONTX). What is Forward Pharma A/S's stock symbol? Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP." What is Forward Pharma A/S's stock price today? One share of FWP stock can currently be purchased for approximately $1.95. How much money does Forward Pharma A/S make? Forward Pharma A/S (NASDAQ:FWP) has a market capitalization of $13.83 million. How can I contact Forward Pharma A/S? Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The official website for the company is www.forward-pharma.com. The biotechnology company can be reached via phone at (453) 344-4242 or via email at investors@forward-pharma.com. This page (NASDAQ:FWP) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.